Available treatments for hepatitis C virus cost-effective when initiated early
New treatments for hepatitis C virus (HCV) may be highly effective but are associated with substantial costs that may compel clinicians and patients to consider delaying treatment. However, a new study shows that immediate treatment of HCV-infected patients with moderate or advanced liver scarring is cost-effective. Immediate treatment of patients with minimal or no scarring can be cost-effective as well, particularly when lower treatment costs are assumed.
"The devastating effects of hepatitis C continue to threaten the health of many Americans, with baby boomers at ...


